Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2

MLA

Brigitte Müller-Hilke, et al. “Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2.” Vaccines, vol. 10, no. 2, Feb. 2022, p. 322. EBSCOhost, https://doi.org/10.3390/vaccines10020322.

APA

Brigitte Müller-Hilke, Franz Mai, Michael Müller, Johann Volzke, & Emil C. Reisinger. (2022). Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2. Vaccines, 10(2), 322. https://doi.org/10.3390/vaccines10020322

Chicago

Brigitte Müller-Hilke, Franz Mai, Michael Müller, Johann Volzke, and Emil C. Reisinger. 2022. “Higher SARS-CoV-2 Spike Binding Antibody Levels and Neutralization Capacity 6 Months after Heterologous Vaccination with AZD1222 and BNT162b2.” Vaccines 10 (2): 322. doi:10.3390/vaccines10020322.